(Reuters) - Illumina and Life Technologies are sitting at the top of the market for genome sequencing, but next-generation companies with big ideas to cut the cost of sequencing are nipping at their heels.
(Reuters) - Illumina and Life Technologies are sitting at the top of the market for genome sequencing, but next-generation companies with big ideas to cut the cost of sequencing are nipping at their heels.
